Search
Nelumbo nucifera flower
go.drugbank.com/drugs/DB14333ApprovedNelumbo nucifera flower is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Arnica montana flower
go.drugbank.com/drugs/DB14343ApprovedArnica montana flower is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Equisetum arvense top
go.drugbank.com/drugs/DB14349ApprovedWithdrawnEquisetum arvense top is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Synonyms: Extract of the Sterile Caules of Equisetum ArvenseSevuparin
go.drugbank.com/drugs/DB15007InvestigationalSevuparin is under investigation in clinical trial NCT03853421 (Placebo-controlled Study to Determine the Safety and Tolerability of Subcutaneous Doses of Sevuparin).
PRX-ASL
go.drugbank.com/drugs/DB17679ExperimentalPRX-ASL is an intracellular enzyme replacement therapy designed to replace the missing or defective enzyme in patients with argininosuccinate lyase deficiency.
MBL-HCV1
go.drugbank.com/drugs/DB17776InvestigationalMBL-HCV1 is a monoclonal antibody developed to prevent the recurrence of hepatitis C virus (HCV) in patients receiving a liver transplant.
Salix alba bark
go.drugbank.com/drugs/DB14274ApprovedSalix alba bark is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
GZ-389988
go.drugbank.com/drugs/DB16056InvestigationalWith Painful Osteoarthritis of the Knee). … GZ-389988 is under investigation in clinical trial NCT02845271 (Proof-of-concept Study to Assess the Efficacy, Tolerability and Safety of a Single Intraarticular Dose of GZ389988 Versus Placebo in Patients
Tabirafusp tedromer
go.drugbank.com/drugs/DB19340InvestigationalTabirafusp tedromer is under investigation in clinical trial NCT06556368 (A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants
MOPEVAC-Las
go.drugbank.com/drugs/DB33987ExperimentalMOPEVAC-Las is under investigation in clinical trial NCT07833436 (A Randomized, Placebo-controlled Trial, to Evaluate the Safety, Immunogenicity and the Optimal Dose of MOPEVAC-Las Vaccine Candidate Against